UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.432

Sortiert nach

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation

The American journal of gastroenterology, 2017-04, Vol.112 (4), p.613-621

2017

Volltextzugriff (PDF)

Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation

Expert opinion on pharmacotherapy, 2018-08, Vol.19 (12), p.1381-1388

Miner, Philip B.

2018

Volltextzugriff (PDF)

Benefit–Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation

Drug safety, 2019-05, Vol.42 (5), p.603-615

Miner, Philip B.

2019

Volltextzugriff (PDF)

Effect of Treatment on the Risk of Viral Infections in Inflammatory Bowel Disease

Clinical gastroenterology and hepatology, 2019-07, Vol.17 (8), p.1648-1649

Miner, Philip B.

2019

Volltextzugriff (PDF)

Irritable Bowel Syndrome Symptoms Following Giardiasis

Clinical gastroenterology and hepatology, 2019-06, Vol.17 (7), p.1416-1416

Miner, Philip B.

2019

Volltextzugriff (PDF)

Economic and personal impact of fecal and urinary incontinence

Gastroenterology (New York, N.Y. 1943), 2004, Vol.126 (1 Suppl 1), p.S8-S13

Miner, Philip B

2004

Volltextzugriff (PDF)

Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome

Expert opinion on pharmacotherapy, 2018-01, Vol.19 (2), p.177-183

Miner, Philip B.

2018

Volltextzugriff (PDF)

Activation of Trace Amine-Associated Receptor 1 Stimulates an Antiapoptotic Signal Cascade via Extracellular Signal-Regulated Kinase 1/2

Molecular pharmacology, 2019-10, Vol.96 (4), p.493-504

2019

Volltextzugriff (PDF)

A Phase II dose ranging, double‐blind, placebo‐controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left‐sided ulcerative colitis

Alimentary pharmacology & therapeutics, 2006-05, Vol.23 (10), p.1415-1425

2006

Volltextzugriff (PDF)

Randomised clinical trial: the safety and efficacy of AST‐120 in non‐constipating irritable bowel syndrome – a double‐blind, placebo‐controlled study

Alimentary pharmacology & therapeutics, 2011-10, Vol.34 (8), p.868-877

2011

Volltextzugriff (PDF)

Ecological consequences of phenotypic plasticity

Trends in ecology & evolution (Amsterdam), 2005-12, Vol.20 (12), p.685-692

2005

Volltextzugriff (PDF)

Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left‐sided ulcerative colitis: a randomized, double‐blind, active‐controlled trial

Alimentary pharmacology & therapeutics, 2006-05, Vol.23 (10), p.1403-1413

2006

Volltextzugriff (PDF)

Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic Constipation

Digestive diseases and sciences, 2011-09, Vol.56 (9), p.2639-2645, Article 2639

2011

Volltextzugriff (PDF)

Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation Treated With Plecanatide

Clinical and translational gastroenterology, 2023-07, Vol.14 (7), p.e00598-e00598

2023

Volltextzugriff (PDF)

Risk Propensity Differences Between Managers and Entrepreneurs and Between Low- and High-Growth Entrepreneurs: A Reply in a More Conservative Vein

Journal of applied psychology, 2004-02, Vol.89 (1), p.3-13

2004

Volltextzugriff (PDF)

Atomic layer deposition of ZnSe/CdSe superlattice nanowires

Applied physics letters, 2002-11, Vol.81 (20), p.3864-3866

2002

Volltextzugriff (PDF)

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

The lancet. Gastroenterology & hepatology, 2017-07, Vol.2 (7), p.479-493

2017

Volltextzugriff (PDF)

Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric‐coated aspirin 325 mg + immediate‐release omeprazole 40 mg) or enteric‐coated aspirin 325 mg + enteric‐coated omeprazole 40 mg – a randomised, phase 1, crossover study

Alimentary pharmacology & therapeutics, 2013-07, Vol.38 (1), p.62-71

2013

Volltextzugriff (PDF)

Response to Currie et al

The American journal of gastroenterology, 2017-11, Vol.112 (11), p.1751-1751

Miner, Philip B

2017

Volltextzugriff (PDF)

Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments

Drug and alcohol dependence, 2021-10, Vol.227, p.108974-108974, Article 108974

2021

Volltextzugriff (PDF)

Plecanatide for the treatment of constipation-predominant irritable bowel syndrome

Expert review of gastroenterology & hepatology, 2020-02, Vol.14 (2), p.71-84

Miner, Philip B

2020

Volltextzugriff (PDF)

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis

Alimentary pharmacology & therapeutics, 2006-05, Vol.23 (10), p.1427-1434

2006

Volltextzugriff (PDF)

Organizational Behavior 6: Integrated Theory Development and the Role of the Unconscious

Miner, John B

1, 2011

Volltextzugriff (PDF)

Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study

BMC gastroenterology, 2014-11, Vol.14 (1), p.188-188, Article 188

2014

Volltextzugriff (PDF)

Review article: physiologic and clinical effects of proton pump inhibitors on non‐acidic and acidic gastro‐oesophageal reflux

Alimentary pharmacology & therapeutics, 2006-03, Vol.23 (s1), p.25-32

MINER, P. B.

2006

Volltextzugriff (PDF)

1 – 25 von 1.432

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.156)
Mit Volltextzugriff
(1.175)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(1.396)
Japanisch
(143)
Deutsch
(31)
Spanisch
(5)
Französisch
(3)
Norwegisch
(1)

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(628)
Life Sciences & Biomedicine
(517)
Humans
(413)
Male
(279)
Female
(247)
Biological And Medical Sciences
(245)
Medical Sciences
(191)
Adult
(183)
Middle Aged
(150)
Social Sciences
(148)
Animals
(136)
Aged
(103)
Psychology
(101)
Adolescent
(87)
Gastroenterology & Hepatology
(83)
Physical Sciences
(74)
Pharmacology & Pharmacy
(72)
Mice
(71)
Business & Economics
(70)
Fundamental And Applied Biological Sciences. Psychology
(65)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

A Randomized Phase III Clinical Trial of Plecanatide, a Uroguanylin Analog, in Patients With Chronic Idiopathic Constipation

Elobixibat, the first-in-class Ileal Bile Acid Transporter inhibitor, for the treatment of Chronic Idiopathic Constipation

Benefit–Risk Assessment of Plecanatide in the Treatment of Chronic Idiopathic Constipation

Effect of Treatment on the Risk of Viral Infections in Inflammatory Bowel Disease

Irritable Bowel Syndrome Symptoms Following Giardiasis

Economic and personal impact of fecal and urinary incontinence

Efficacy and safety of plecanatide in treating constipation predominant irritable bowel syndrome

Activation of Trace Amine-Associated Receptor 1 Stimulates an Antiapoptotic Signal Cascade via Extracellular Signal-Regulated Kinase 1/2

A Phase II dose ranging, double‐blind, placebo‐controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left‐sided ulcerative colitis

Randomised clinical trial: the safety and efficacy of AST‐120 in non‐constipating irritable bowel syndrome – a double‐blind, placebo‐controlled study

Ecological consequences of phenotypic plasticity

Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left‐sided ulcerative colitis: a randomized, double‐blind, active‐controlled trial

Long-Term Safety and Effectiveness of Lubiprostone, a Chloride Channel (ClC-2) Activator, in Patients with Chronic Idiopathic Constipation

Influence of Demographic Factors on Clinical Outcomes in Adults With Chronic Idiopathic Constipation Treated With Plecanatide

Risk Propensity Differences Between Managers and Entrepreneurs and Between Low- and High-Growth Entrepreneurs: A Reply in a More Conservative Vein

Atomic layer deposition of ZnSe/CdSe superlattice nanowires

Epitope-specific immunotherapy targeting CD4-positive T cells in coeliac disease: two randomised, double-blind, placebo-controlled phase 1 studies

Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric‐coated aspirin 325 mg + immediate‐release omeprazole 40 mg) or enteric‐coated aspirin 325 mg + enteric‐coated omeprazole 40 mg – a randomised, phase 1, crossover study

Response to Currie et al

Fentanyl causes naloxone-resistant vocal cord closure: A platform for testing opioid overdose treatments

Plecanatide for the treatment of constipation-predominant irritable bowel syndrome

Bioavailability and therapeutic activity of alicaforsen (ISIS 2302) administered as a rectal retention enema to subjects with active ulcerative colitis

Organizational Behavior 6: Integrated Theory Development and the Role of the Unconscious

Dose-dependent effects of lesogaberan on reflux measures in patients with refractory gastroesophageal reflux disease: a randomized, placebo-controlled study

Review article: physiologic and clinical effects of proton pump inhibitors on non‐acidic and acidic gastro‐oesophageal reflux

Suchergebnisse filtern